Production (Stage)
Nektar Therapeutics
NKTR
$0.666
-$0.0088-1.30%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -24.41% | -15.94% | -34.39% | -33.75% | -36.69% |
| Total Receivables | -68.45% | -28.55% | -38.10% | -25.05% | 81.40% |
| Inventory | -- | -- | -- | -30.08% | -19.75% |
| Prepaid Expenses | -46.92% | -43.05% | -50.80% | -37.57% | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 54.37% | -54.98% | 1,737.79% | 29.07% | -56.70% |
| Total Current Assets | -28.12% | -20.99% | -28.20% | -33.07% | -34.87% |
|
|
|||||
| Total Current Assets | -28.12% | -20.99% | -28.20% | -33.07% | -34.87% |
| Net Property, Plant & Equipment | -67.87% | -67.92% | -67.88% | -52.63% | -49.85% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 15.79% | 0.06% | -0.09% | 161.14% | 231.15% |
| Total Assets | -35.29% | -23.66% | -30.36% | -30.54% | -29.50% |
|
|
|||||
| Total Accounts Payable | 103.65% | 17.38% | 160.86% | 147.23% | 136.93% |
| Total Accrued Expenses | 42.66% | 42.12% | 28.97% | 21.18% | -34.56% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 12.77% | 3.16% | 12.62% | 12.70% | 3.17% |
| Total Finance Division Other Current Liabilities | -35.10% | -8.38% | 17.09% | -55.57% | -37.42% |
| Total Other Current Liabilities | -35.10% | -8.38% | 17.09% | -55.57% | -37.42% |
| Total Current Liabilities | 35.35% | 19.76% | 29.69% | 13.08% | -12.48% |
|
|
|||||
| Total Current Liabilities | 35.35% | 19.76% | 29.69% | 13.08% | -12.48% |
| Long-Term Debt | -26.76% | -18.51% | -20.86% | -20.75% | -18.79% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -17.12% | -16.06% | -15.10% | -14.23% | -13.42% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 55.88% | 56.22% | 39.33% | 56.30% | -33.11% |
| Total Liabilities | -9.95% | -8.96% | -8.41% | -11.33% | -16.07% |
|
|
|||||
| Common Stock & APIC | 0.54% | 1.43% | 1.50% | 1.58% | 1.66% |
| Retained Earnings | -3.79% | -3.42% | -4.90% | -5.22% | -5.27% |
| Treasury Stock & Other | 12.99% | -3,773.75% | 58.36% | 45.83% | 40.10% |
| Total Common Equity | -89.16% | -53.63% | -69.33% | -59.54% | -47.40% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -89.16% | -53.63% | -69.33% | -59.54% | -47.40% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -89.16% | -53.63% | -69.33% | -59.54% | -47.40% |
|
|
|||||